ANAY VALLEJO: Open Payments
NPI 1225513963 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,091 in 142 payments from 20 companies in 2025. Trend: 2023 $2,831 · 2024 $3,082 · 2025 $3,091
Food & beverage: $3,091
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $666 |
| Amgen Inc. | 19 | $487 |
| UCB, Inc. | 14 | $371 |
| AstraZeneca Pharmaceuticals LP | 9 | $280 |
| Janssen Biotech, Inc. | 10 | $267 |
| Novartis Pharmaceuticals Corporation | 10 | $166 |
| GlaxoSmithKline, LLC. | 9 | $151 |
| ANI Pharmaceuticals, Inc. | 5 | $115 |
| PFIZER INC. | 5 | $109 |
| Merck Sharp & Dohme LLC | 4 | $92 |
Products named: Bimzelx, SKYRIZI, RINVOQ, SAPHNELO, TREMFYA, ENBREL, EVENITY, COSENTYX.
Industry payments across TX — which companies pay providers there.
